Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Apr;108(4):941–947. doi: 10.1111/j.1476-5381.1993.tb13490.x

Relaxing actions of corticotropin-releasing factor on rat resistance arteries.

S Lei 1, R Richter 1, M Bienert 1, M J Mulvany 1
PMCID: PMC1908147  PMID: 8485633

Abstract

1. Although it well established that corticotropin-releasing factor (CRF) injected i.v. can cause hypotension and vasodilatation, there is no in vitro evidence that CRF acts as a vasodilator. We have therefore tested the hypothesis that the hypotensive effect of i.v. CRF is due to a direct vasodilator action by carrying out experiments in vitro on rat resistance arteries (i.d. 150-300 microns). 2. Initial in vivo experiments confirmed that CRF (1.5 nmol.kg-1) injected i.v. caused hypotension in rats, this being partially antagonized by the CRF analogue CRF9-41. 3. For the in vitro experiments, vessels were taken from the mesenteric, cerebral and femoral vascular beds, and mounted as ring preparations in an isometric myograph. The vessels were pre-contracted with one of 3 agonists (prostaglandin F2 alpha, arginine vasopressin or noradrenaline) or with a high-potassium solution (K+). 4. With maximal concentrations of the agonists, CRF caused relaxation of mesenteric and cerebral vessels with 10 nM, and near complete relaxation with 100 nM. Femoral vessels pre-constricted with agonists and all vessels pre-constricted with K+ were less affected by CRF. In the mesenteric vessels, with sub-maximal levels of pre-constriction, CRF caused substantial relaxation at 1 nM and could cause complete relaxation at 10 nM. 5. The relaxant effect of CRF on contractions of mesenteric vessels was antagonized by 100 nM CRF9-41. Neither tetraethyl ammonium (30 mM) nor glibenclamide (3 microM) antagonized the relaxant effect of CRF. 6. The relaxant effect of CRF on mesenteric small arteries was found to be unaffected by removal of the endothelium.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
941

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aalkjaer C., Danielsen H., Johannesen P., Pedersen E. B., Rasmussen A., Mulvany M. J. Abnormal vascular function and morphology in pre-eclampsia: a study of isolated resistance vessels. Clin Sci (Lond) 1985 Oct;69(4):477–482. doi: 10.1042/cs0690477. [DOI] [PubMed] [Google Scholar]
  2. Baumbach G. L., Dobrin P. B., Hart M. N., Heistad D. D. Mechanics of cerebral arterioles in hypertensive rats. Circ Res. 1988 Jan;62(1):56–64. doi: 10.1161/01.res.62.1.56. [DOI] [PubMed] [Google Scholar]
  3. Bolt G. R., Itoh H., Lederis K., MacCannell K. L. Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated vasoconstrictor responses by a vasodilator peptide, urotensin I: comparison with nifedipine. J Pharmacol Exp Ther. 1989 Dec;251(3):1147–1154. [PubMed] [Google Scholar]
  4. Brown M. R., Fisher L. A. Central nervous system effects of corticotropin releasing factor in the dog. Brain Res. 1983 Nov 28;280(1):75–79. doi: 10.1016/0006-8993(83)91175-7. [DOI] [PubMed] [Google Scholar]
  5. Brown M. R., Gray T. S., Fisher L. A. Corticotropin-releasing factor receptor antagonist: effects on the autonomic nervous system and cardiovascular function. Regul Pept. 1986 Dec 30;16(3-4):321–329. doi: 10.1016/0167-0115(86)90032-7. [DOI] [PubMed] [Google Scholar]
  6. Bruhn T. O., Engeland W. C., Anthony E. L., Gann D. S., Jackson I. M. Corticotropin-releasing factor in the dog adrenal medulla is secreted in response to hemorrhage. Endocrinology. 1987 Jan;120(1):25–33. doi: 10.1210/endo-120-1-25. [DOI] [PubMed] [Google Scholar]
  7. Campbell E. A., Linton E. A., Wolfe C. D., Scraggs P. R., Jones M. T., Lowry P. J. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab. 1987 May;64(5):1054–1059. doi: 10.1210/jcem-64-5-1054. [DOI] [PubMed] [Google Scholar]
  8. Chrousos G. P., Gold P. W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992 Mar 4;267(9):1244–1252. [PubMed] [Google Scholar]
  9. Corder R., Turnill D., Ling N., Gaillard R. C. Attenuation of corticotropin releasing factor-induced hypotension in anesthetized rats with the CRF antagonist, alpha-helical CRF9-41; comparison with effect on ACTH release. Peptides. 1992 Jan-Feb;13(1):1–6. doi: 10.1016/0196-9781(92)90132-m. [DOI] [PubMed] [Google Scholar]
  10. Dashwood M. R., Andrews H. E., Wei E. T. Binding of [125I]Tyr-corticotropin-releasing factor to rabbit aorta is reduced by removal of the endothelium. Eur J Pharmacol. 1987 Mar 3;135(1):111–112. doi: 10.1016/0014-2999(87)90766-7. [DOI] [PubMed] [Google Scholar]
  11. Edwards A. V., Jones C. T. Secretion of corticotrophin releasing factor from the adrenal during splanchnic nerve stimulation in conscious calves. J Physiol. 1988 Jun;400:89–100. doi: 10.1113/jphysiol.1988.sp017112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fisher L. A., Brown M. R. Central regulation of stress responses: regulation of the autonomic nervous system and visceral function by corticotrophin releasing factor-41. Baillieres Clin Endocrinol Metab. 1991 Mar;5(1):35–50. doi: 10.1016/s0950-351x(05)80095-3. [DOI] [PubMed] [Google Scholar]
  13. Fisher L. A. Corticotropin-releasing factor: endocrine and autonomic integration of responses to stress. Trends Pharmacol Sci. 1989 May;10(5):189–193. doi: 10.1016/0165-6147(89)90236-8. [DOI] [PubMed] [Google Scholar]
  14. Fisher L. A., Jessen G., Brown M. R. Corticotropin-releasing factor (CRF): mechanism to elevate mean arterial pressure and heart rate. Regul Pept. 1983 Jan;5(2):153–161. doi: 10.1016/0167-0115(83)90123-4. [DOI] [PubMed] [Google Scholar]
  15. Gao G. C., Dashwood M. R., Wei E. T. Corticotropin-releasing factor inhibition of substance P-induced vascular leakage in rats: possible sites of action. Peptides. 1991 May-Jun;12(3):639–644. doi: 10.1016/0196-9781(91)90113-4. [DOI] [PubMed] [Google Scholar]
  16. Gardiner S. M., Compton A. M., Bennett T. Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats. Br J Pharmacol. 1988 Sep;95(1):197–208. doi: 10.1111/j.1476-5381.1988.tb16565.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gerritsen M. E., Morgan D. O., Parks T. P., Printz M. P., Lederis K. P. A proposed role for prostaglandins in the modulation of the relaxation response to urotensin I in isolated rat arteries. Prostaglandins. 1981 Dec;22(6):873–892. doi: 10.1016/0090-6980(81)90018-6. [DOI] [PubMed] [Google Scholar]
  18. Grosskreutz C. L., Brody M. J. Regional hemodynamic responses to central administration of corticotropin-releasing factor (CRF). Brain Res. 1988 Mar 1;442(2):363–367. doi: 10.1016/0006-8993(88)91527-2. [DOI] [PubMed] [Google Scholar]
  19. Hermus A. R., Pieters G. F., Willemsen J. J., Ross H. A., Smals A. G., Benraad T. J., Kloppenborg P. W. Hypotensive effects of ovine and human corticotrophin-releasing factors in man. Eur J Clin Pharmacol. 1987;31(5):531–534. doi: 10.1007/BF00606625. [DOI] [PubMed] [Google Scholar]
  20. Hohtari H., Elovainio R., Salminen K., Laatikainen T. Plasma corticotropin-releasing hormone, corticotropin, and endorphins at rest and during exercise in eumenorrheic and amenorrheic athletes. Fertil Steril. 1988 Aug;50(2):233–238. doi: 10.1016/s0015-0282(16)60065-1. [DOI] [PubMed] [Google Scholar]
  21. Jones C. T., Edwards A. V. Adrenal responses to corticotrophin-releasing factor in conscious hypophysectomized calves. J Physiol. 1990 Nov;430:25–36. doi: 10.1113/jphysiol.1990.sp018279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kiang J. G., Wei E. T. Corticotropin-releasing factor inhibits thermal injury. J Pharmacol Exp Ther. 1987 Nov;243(2):517–520. [PubMed] [Google Scholar]
  23. Lederis K., Letter A., McMaster D., Ichikawa T., MacCannell K. L., Kobayashi Y., Rivier J., Rivier C., Vale W., Fryer J. Isolation, analysis of structure, synthesis, and biological actions of urotensin I neuropeptides. Can J Biochem Cell Biol. 1983 Jul;61(7):602–614. doi: 10.1139/o83-076. [DOI] [PubMed] [Google Scholar]
  24. Lenz H. J. Extrapituitary effects of corticotropin-releasing factor. Horm Metab Res Suppl. 1987;16:17–23. [PubMed] [Google Scholar]
  25. MacCannell K. L., Lederis K. Mammalian pharmacology of the fish neuropeptide urotensin I. Fed Proc. 1983 Jan;42(1):91–95. [PubMed] [Google Scholar]
  26. MacCannell K. L., Newton C. A., Lederis K., Rivier J., Tiffany M. Use of selective mesenteric vasodilator peptides in experimental nonocclusive mesenteric ischemia in the dog. Gastroenterology. 1986 Mar;90(3):669–676. doi: 10.1016/0016-5085(86)91122-4. [DOI] [PubMed] [Google Scholar]
  27. Mulvany M. J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977 Jul;41(1):19–26. doi: 10.1161/01.res.41.1.19. [DOI] [PubMed] [Google Scholar]
  28. Mulvany M. J., Nyborg N. An increased calcium sensitivity of mesenteric resistance vessels in young and adult spontaneously hypertensive rats. Br J Pharmacol. 1980;71(2):585–596. doi: 10.1111/j.1476-5381.1980.tb10977.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Nilsson H., Mulvany M. J. Prolonged exposure to ouabain eliminates the greater norepinephrine-dependent calcium sensitivity of resistance vessels in spontaneously hypertensive rats. Hypertension. 1981 Nov-Dec;3(6):691–697. doi: 10.1161/01.hyp.3.6.691. [DOI] [PubMed] [Google Scholar]
  30. Overton J. M., Fisher L. A. Central nervous system actions of corticotropin-releasing factor on cardiovascular function in the absence of locomotor activity. Regul Pept. 1989 Jun-Jul;25(3):315–324. doi: 10.1016/0167-0115(89)90179-1. [DOI] [PubMed] [Google Scholar]
  31. Owens M. J., Nemeroff C. B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev. 1991 Dec;43(4):425–473. [PubMed] [Google Scholar]
  32. Pralong F. P., Corder R., Gaillard R. C. Responses of the rat pituitary-adrenal axis to hypotensive infusions of corticotropin-releasing factor, vasoactive intestinal peptide and other depressor agents. Regul Pept. 1991 Feb 1;32(2):217–226. doi: 10.1016/0167-0115(91)90048-l. [DOI] [PubMed] [Google Scholar]
  33. Rivier J., Rivier C., Vale W. Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. Science. 1984 May 25;224(4651):889–891. doi: 10.1126/science.6326264. [DOI] [PubMed] [Google Scholar]
  34. Saitoh M., Hasegawa J., Mashiba H. Effect of corticotropin-releasing factor on the electrical and mechanical activities of the guinea-pig ventricular myocardium. Gen Pharmacol. 1990;21(3):337–342. doi: 10.1016/0306-3623(90)90834-9. [DOI] [PubMed] [Google Scholar]
  35. Sasaki A., Shinkawa O., Margioris A. N., Liotta A. S., Sato S., Murakami O., Go M., Shimizu Y., Hanew K., Yoshinaga K. Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery. J Clin Endocrinol Metab. 1987 Feb;64(2):224–229. doi: 10.1210/jcem-64-2-224. [DOI] [PubMed] [Google Scholar]
  36. Taylor A. L., Fishman L. M. Corticotropin-releasing hormone. N Engl J Med. 1988 Jul 28;319(4):213–222. doi: 10.1056/NEJM198807283190405. [DOI] [PubMed] [Google Scholar]
  37. Udelsman R., Gallucci W. T., Bacher J., Loriaux D. L., Chrousos G. P. Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey. Peptides. 1986 May-Jun;7(3):465–471. doi: 10.1016/0196-9781(86)90016-1. [DOI] [PubMed] [Google Scholar]
  38. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 1981 Sep 18;213(4514):1394–1397. doi: 10.1126/science.6267699. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES